Cytochrome P‐450 isozyme/isozyme functional interactions and NADPH‐cytochrome P‐450 reductase concentrations as factors in microsomal metabolism of warfarin
- 1 June 1985
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 149 (3) , 479-489
- https://doi.org/10.1111/j.1432-1033.1985.tb08950.x
Abstract
The basis for our previous observations [Kaminsky, L. S., Guengerich, F. P., Dannan, G. A. & Aust, S. D. (1983) Arch. Biochem. Biophys. 225, 398–404] that rates of microsomal metabolism of warfarin were markedly less than the sum of rates of the reconstituted constituent isozymes of cytochrome P‐450 has been investigated. Metabolism of warfarin to 4′‐, 6‐, 7‐, 8‐, and 10‐hydroxywarfarin and dehydrowarfarin by highly purified rat liver cytochrome P‐450 (P‐450) isozymes reconstituted with NADPH–cytochrome P‐450 reductase and by hepatic microsomes from variously pretreated rats was used to probe functional consequences of P‐450 isozyme/isozyme interactions and of the effect of microsomal reductase concentrations. Binary mixtures of P‐450 isozymes were reconstituted and the regioselectivity and stereoselectivity were used to probe metabolism by each individual isozyme. The isozymes specifically inhibited each other to variable extents and the order of inhibitory potency was: P‐450UT‐F > P‐450PB‐D≥ P‐450UT‐A≥ P‐450BNF/ISF‐G > P‐450PB/PCN‐E > P‐450PB‐B≥ P‐450PB‐C≥ P‐450BNF‐B. The inhibition, possibly a consequence of aggregation, explains the low rate of microsomal metabolism relative to the metabolic potential of the component P‐450 isozymes. When purified reductase was added to microsomes it appeared to bind to microsomes at different sites from endogenous reductase and it enhanced warfarin hydroxylase activity only to a minor extent, thus possibly precluding low reductase concentrations from being a major factor in the relatively low rates of microsomal metabolism. Antibody to the reductase differentially inhibited microsomal metabolism of warfarin by the various P‐450 isozymes. The results suggest that the reductase and P‐450 isozymes may be located differently relative to one another in the various microsomal preparations.This publication has 43 references indexed in Scilit:
- Purification and characterization of six cytochrome P-450 isozymes from human liver microsomesBiochemistry, 1983
- Immunological comparison of rat, rabbit, and human liver NADPH-cytochrome P-450 reductasesBiochemistry, 1981
- Evidence from cross‐linking and rotational diffusion studies that cytochrome P450 can form molecular aggregates in rabbit‐liver microsomal membranesFEBS Letters, 1980
- Cross-linking studies of cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductaseBiochemistry, 1980
- Isolation and purification of cytochrome P-450, and the existence of multiple formsPharmacology & Therapeutics, 1979
- Stimulation of microsomal drug oxidation activities by incorporation into microsomes of purified NADPH-cytochrome c (P-450) reductase.The Japanese Journal of Pharmacology, 1979
- The binding of NADPH-cytochrome c reductase to rat liver microsomesBiochemical and Biophysical Research Communications, 1977
- Stimulation of microsomal N-demethylation by solubilized NADPH-cytochrome c reductaseLife Sciences, 1976
- Highly purified detergent-solubilized NADPH-cytochrome P-450 reductase from phenobarbital-induced rat liver microsomesBiochemical and Biophysical Research Communications, 1974
- The resolution and reconstitution of the liver microsomal hydroxylation systemBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1974